Influenza A Virus: Pathogen, Pathogenesis & Host Defenses
This paper provides a detailed overview of influenza A, a highly virulent respiratory illness caused by a member of the family Orthomyxoviridae. Beginning with clinical symptoms and potential complications — including pneumonia, secondary infections, and death — the paper moves through the biological description of the influenza A virion, including its lipid bilayer envelope, hemagglutinin and neuraminidase surface proteins, and eight-segment RNA genome. It examines reservoirs of the virus in wild birds and swine, explains the mechanism of antigenic shift that can produce new pandemic strains, and concludes with an account of tissue-level pathogenesis and the host immune response, particularly the role of antibodies in combating infection.
- Introduction: Influenza Symptoms and Complications: Clinical symptoms, complications, and mortality statistics
- Description of the Pathogen: Virion structure, RNA genome, and morphology
- Reservoir: Where the Pathogen Is Found: Birds, swine, and antigenic shift mechanisms
- Pathogenesis: Tissue damage and viral replication process
- Host Defenses: Immune response and antibody action against influenza
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- It follows a logical, science-report structure — moving from clinical presentation to molecular biology to epidemiology — making complex virology accessible without oversimplifying.
- It integrates authoritative sources (CDC, IFPMA, university microbiology departments) at each section, grounding claims in credible references rather than general assertions.
- The explanation of antigenic shift through the pig-as-mixing-vessel model is a particularly clear illustration of an abstract genetic mechanism with real-world pandemic consequences.
Key academic technique demonstrated
The paper demonstrates effective use of technical definition followed by accessible analogy. For example, the RNA genome's function is defined precisely (ribonucleoprotein segments, polymerase subunits) and then connected to observable outcomes like replication and cell death. This pattern — define, explain mechanism, show consequence — makes virology content readable for a general academic audience.
Structure breakdown
The paper opens with a clinical introduction covering symptoms and historical mortality data. It then moves through three descriptive science sections: pathogen structure (virion morphology, RNA segments, membrane proteins), reservoir ecology (wild birds, swine, antigenic shift), and pathogenesis (tissue damage, viral replication). A final section on host defenses explains the immune response at the cellular level. The conclusion is embedded within the host defenses section rather than presented as a standalone paragraph.
Introduction: Influenza Symptoms and Complications
The disease known as influenza is a respiratory illness caused by flu viruses. Influenza is not to be confused with the common cold. It may originally start out with some cold-like symptoms, but very quickly the person affected by the flu virus will suffer far more serious symptoms. According to the Centers for Disease Control and Prevention (CDC), the following symptoms will be present: fever (and chills); cough; sore throat; runny or stuffy nose; muscle or body aches; headaches; tiredness/fatigue; and a possibility of diarrhea and vomiting. The CDC asserts that "not everyone with flu will have a fever" (CDC).
What are the complications associated with influenza? The CDC reports that the average person attacked by the influenza virus recovers in less than two weeks, but there are serious complications — which is why the government and many healthcare professionals recommend a flu shot at the beginning of the winter season. The influenza virus can lead to pneumonia, bronchitis, and sinus and ear infections, and in some cases people die from the virus (CDC). During the 1990s, there were an estimated 17,000 deaths during the least serious flu season and approximately 52,000 deaths during the most severe flu season. The flu virus that struck in 2009 (H1N1) took approximately 12,000 lives in the United States alone. What worries healthcare professionals is that people who have existing health problems — for example, those with asthma or chronic congestive heart failure — may find that the influenza virus worsens their conditions.
Description of the Pathogen
The virus that is the subject of this paper is influenza A. Influenza A has two surface protein subtypes: hemagglutinin (H) and neuraminidase (N). Within hemagglutinin there are 16 different subtypes, and there are 9 different neuraminidase subtypes (CDC).
Influenza viruses (IFVs) are members of the family Orthomyxoviridae; the influenza A virus (IFAV) belongs to the genus Influenzavirus A. Influenza A is the most virulent of the three influenza types. It is the cause of pandemics and flu epidemics, and is known to have an avian host as an intermediate reservoir.
The influenza A virion is a globular particle roughly 100 nanometers in diameter. It is sheathed in a lipid bilayer derived from the plasma membrane of its host. Inside the lipid bilayer are two membrane proteins that are integral to the replication process.
These two membrane proteins include approximately 500 hemagglutinin (H) molecules and 100 molecules of neuraminidase (N). Within the lipid bilayer, some 3,000 molecules of matrix protein are found along with 8 segments of RNA. RNA (ribonucleic acid) is a chain of nucleotides present in the cells of all living organisms. Its functions include regulatory control over gene expression and assistance in the process of gene copying.
Each of the 8 RNA segments produces multiple copies of a nucleoprotein and several molecules of RNA polymerase (comprising 3 polymerase subunits). Each of the 8 segments can also be broken down into the genes that make up influenza A: the HA gene; the NA gene; the NP gene; the M gene; the NS gene; and 6–8 genes housed in one RNA molecule (PA, PB1, PB2) for each of the 3 subunits of RNA polymerase (Kimball, 2009).
Regarding the morphology of the influenza A virus: when a person contracts the virus from another human, typically an acutely infected individual sneezes and the tiny droplets are inhaled into the pharynx (lower respiratory tract). The spread then has an incubation period of approximately one to three days. The virion is usually round but may have a long filament associated with it. The RNA genome is present in eight separate segments of ribonucleoprotein (RNP), and all 8 segments must be present for replication to occur. The virus enters cells in the lungs by endocytosis. The droplets enter the nose, pass by the tonsillar lymphoid organs, and target the epithelial cells in the trachea and bronchial tubes, carrying the virus into the lungs and from there into the bloodstream.
Create your account
Always verify citation format against your institution’s current style guide requirements.